World's Best Scientists 2026 revealed!
Eric F. Morand

Eric F. Morand

D-Index & Metrics

Microbiology

D-Index
81
Citations
20754
World Ranking
1110
National Ranking
30

Overview

Eric F. Morand is a researcher affiliated with Monash University in Australia. Their main fields of study include Medicine and Immunology and Microbiology, with a particular focus on Rheumatology and Immunology as subfields. Their research extensively covers topics such as Systemic Lupus Erythematosus Research, Monoclonal and Polyclonal Antibodies Research, and Atherosclerosis and Cardiovascular Diseases.

Their work also addresses areas related to Cytokine Signaling Pathways and Interactions, T-cell and B-cell Immunology, Lymphoma Diagnosis and Treatment, and Autoimmune and Inflammatory Disorders Research.

Eric F. Morand has contributed to numerous scientific publications. Among their recent papers are:

  • Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial (2022, Arthritis & Rheumatology)
  • Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I) (2023, The Lancet)

Other key papers relevant to the field, though not authored by Morand, include:

  • EULAR recommendations for the management of systemic lupus erythematosus: 2023 update (2023, Annals of the Rheumatic Diseases)
  • 2021 DORIS definition of remission in SLE: final recommendations from an international task force (2021, Lupus Science & Medicine)
  • Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II) (2023, The Lancet)

Frequent collaborators in Eric F. Morand's research include Alberta Hoi, Rangi Kandane-Rathnayake, Richard Furie, Vera Golder, and Mandana Nikpour.

Their work is often published in notable venues such as Annals of the Rheumatic Diseases, Lupus Science & Medicine, The Lancet Rheumatology, The Journal of Rheumatology, and others.

Best Publications

  • Trial of Anifrolumab in Active Systemic Lupus Erythematosus

    Eric F Morand;Richard Furie;Yoshiya Tanaka;Ian N Bruce

  • Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

    Ronald van Vollenhoven;Marta Mosca;George Bertsias;David Isenberg

  • Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)

    Kate Franklyn;Chak Sing Lau;Sandra V Navarra;Worawit Louthrenoo

  • Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus.

    Jing He;Xia Zhang;Yunbo Wei;Xiaolin Sun

  • The BAFF/APRIL system in SLE pathogenesis

    Fabien B. Vincent;Eric F. Morand;Pascal Schneider;Fabienne Mackay

  • Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial

    Richard A Furie;Eric F Morand;Ian N Bruce;Susan Manzi

  • MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis

    Eric Francis Morand;Michelle Theresa Leech;Jurgen Bernhagen

  • Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective

    Fabien B Vincent;Eric F Morand;Eric F Morand;Kim Murphy;Fabienne Mackay

  • Macrophage migration inhibitory factor in rheumatoid arthritis: Evidence of proinflammatory function and regulation by glucocorticoids

    Michelle Leech;Christine N Metz;Pamela Hall;Paul Hutchinson

  • A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)

    Ronald van Vollenhoven;Alexandre Voskuyl;George Bertsias;Cynthia Aranow

  • Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity

    Heng Yang;Lin Xia;Jian Chen;Shuqing Zhang

  • Antiinflammatory Effect of Lipocortin 1 in Experimental Arthritis

    Yuanhang Yang;Michelle Leech;Paul Hutchinson;Stephen R. Holdsworth

  • Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2.

    Julia Gregory;Eric Francis Morand;Sonja Jane McKeown;Jennifer Ralph

  • Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis.

    Michelle Leech;Christine N Metz;Leilani Santos;Tina Peng

  • Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids

    Leilani Santos;Pamela Hall;Christine N Metz;Richard Bucala

  • Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis.

    Yuan Hang Yang;Eric Francis Morand;Stephen J Getting;Mark Paul-Clark

  • A miR-19 regulon that controls NF-κB signaling

    Michael P. Gantier;H. James Stunden;Claire E. McCoy;Mark A. Behlke

  • Glucocorticoid inhibition of adjuvant arthritis synovial macrophage nitric oxide production: role of lipocortin 1

    Yuan Yang;Paul Hutchinson;Leilani Santos;Eric F Morand

  • Macrophage migration inhibitory factor in systemic lupus erythematosus.

    Andrew Murray Foote;Esther Mary Briganti;Y Kipen;Leilani Llanes Santos

  • Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)

    Unknown

  • Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor

    Annaleise V. Sampey;Pamela H. Hall;Robert A. Mitchell;Christine N. Metz

Frequent Co-Authors

James S. Harris
James S. Harris Stanford University
Chak Sing Lau
Chak Sing Lau University of Hong Kong
Fabienne Mackay
Fabienne Mackay QIMR Berghofer Medical Research Institute
Richard Bucala
Richard Bucala Yale University
Michael J. Hickey
Michael J. Hickey Monash Medical Centre
Anthony M. Dart
Anthony M. Dart Monash University
Ian N. Bruce
Ian N. Bruce University of Manchester
Stephen R. Holdsworth
Stephen R. Holdsworth Monash University
David A. Isenberg
David A. Isenberg University College London
Christine N. Metz
Christine N. Metz Feinstein Institute for Medical Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying Microbiology in the USA, exploring related career paths can provide valuable insights into diverse professional opportunities. Many students also investigate flexible and accessible online degree options that align with their career goals and personal circumstances.

One promising area is healthcare, where roles such as becoming a child life specialists salary can be particularly appealing. These specialists support children and families in medical settings, a field that benefits from a strong foundation in biological sciences.

For individuals seeking alternative pathways, especially those facing barriers to traditional education, it’s important to know which degrees felons can get online. Microbiology-related programs may sometimes be accessible and can lead to meaningful careers in research, quality control, or health services.

Healthcare roles such as functional medicine nurse salary professions show significant growth in the holistic and patient-centered treatment sector. These careers often complement microbiology studies with a focus on health and wellness.

Additionally, specialized certifications like becoming a certified professional coder salary holder offer career stability in healthcare administration and medical billing—fields that support medical research and clinical practice indirectly.

Best Scientists Citing Eric F. Morand

Trending Scientists

Recently Published Articles